ATAZANAVIR\RITONAVIR: 478 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
478
Total FAERS Reports
22 (4.6%)
Deaths Reported
64
Hospitalizations
478
As Primary/Secondary Suspect
8
Life-Threatening
2
Disabilities
First Report: 20030101 · Latest Report: 20210614
What Are the Most Common ATAZANAVIR\RITONAVIR Side Effects?
#1 Most Reported
Virologic failure
110 reports (23.0%)
#2 Most Reported
Pathogen resistance
53 reports (11.1%)
#3 Most Reported
Drug resistance
52 reports (10.9%)
All ATAZANAVIR\RITONAVIR Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Virologic failure | 110 | 23.0% | 6 | 2 |
| Pathogen resistance | 53 | 11.1% | 0 | 1 |
| Drug resistance | 52 | 10.9% | 0 | 3 |
| Viral mutation identified | 46 | 9.6% | 0 | 0 |
| Csf hiv escape syndrome | 41 | 8.6% | 2 | 0 |
| Treatment failure | 31 | 6.5% | 1 | 1 |
| Immune reconstitution inflammatory syndrome | 28 | 5.9% | 0 | 17 |
| Treatment noncompliance | 28 | 5.9% | 2 | 7 |
| Csf virus identified | 27 | 5.7% | 0 | 0 |
| Drug interaction | 24 | 5.0% | 0 | 5 |
| Hiv test positive | 22 | 4.6% | 0 | 0 |
| Drug ineffective | 21 | 4.4% | 1 | 3 |
| Exposure during pregnancy | 18 | 3.8% | 1 | 1 |
| Neurological symptom | 17 | 3.6% | 4 | 0 |
| Anaemia | 16 | 3.4% | 5 | 7 |
| Chronic kidney disease | 15 | 3.1% | 0 | 5 |
| Condition aggravated | 15 | 3.1% | 2 | 6 |
| Foetal exposure during pregnancy | 15 | 3.1% | 1 | 2 |
| Csf hiv virus identified | 14 | 2.9% | 4 | 0 |
| Renal impairment | 13 | 2.7% | 0 | 0 |
Who Reports ATAZANAVIR\RITONAVIR Side Effects? Age & Gender Data
Gender: 44.2% female, 55.8% male. Average age: 46.5 years. Most reports from: IN. View detailed demographics →
Is ATAZANAVIR\RITONAVIR Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2003 | 5 | 0 | 0 |
| 2008 | 6 | 0 | 0 |
| 2009 | 3 | 0 | 0 |
| 2010 | 9 | 0 | 4 |
| 2012 | 3 | 2 | 0 |
| 2013 | 1 | 0 | 0 |
| 2014 | 4 | 0 | 1 |
| 2015 | 9 | 1 | 2 |
| 2016 | 5 | 0 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 2 | 0 | 2 |
| 2020 | 9 | 1 | 3 |
| 2021 | 8 | 0 | 6 |
What Is ATAZANAVIR\RITONAVIR Used For?
| Indication | Reports |
|---|---|
| Hiv infection | 386 |
| Antiretroviral therapy | 39 |
| Product used for unknown indication | 12 |
| Hiv infection cdc category c | 8 |
| Csf hiv escape syndrome | 7 |
| Hiv-2 infection | 7 |
| Covid-19 | 6 |
ATAZANAVIR\RITONAVIR vs Alternatives: Which Is Safer?
ATAZANAVIR\RITONAVIR vs ATENOLOL
ATAZANAVIR\RITONAVIR vs ATENOLOL\CHLORTHALIDONE
ATAZANAVIR\RITONAVIR vs ATEZOLIZUMAB
ATAZANAVIR\RITONAVIR vs ATLANTIC SALMON OIL
ATAZANAVIR\RITONAVIR vs ATOGEPANT
ATAZANAVIR\RITONAVIR vs ATOMOXETINE
ATAZANAVIR\RITONAVIR vs ATOMOXETINE\ATOMOXETINE
ATAZANAVIR\RITONAVIR vs ATORVASTATIN
ATAZANAVIR\RITONAVIR vs ATORVASTATIN\EZETIMIBE
ATAZANAVIR\RITONAVIR vs ATOSIBAN
Official FDA Label for ATAZANAVIR\RITONAVIR
Official prescribing information from the FDA-approved drug label.